- Correction
- Open access
- Published:
Correction to: Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala
AIDS Research and Therapy volume 19, Article number: 48 (2022)
Correction to: AIDS Res Ther (2020) 17:62 https://doi.org/10.1186/s12981-020-00318-8
In the original publication of this article [1], the authors were notified that there were some errors in Table 2 that were also present in the main text, specifically in the results section of the abstract, the overall sensitivity of the LAM-test of 56.1% with 95% CI of (43.3–68.3) should have been 62.7 with 95% CI of (49.1–75); the LAM-test sensitivity in PLWH with < 200 CD4 T cells/µl of 62.2% (95% CI 46.5–76.2) should have been of 71.8% with 95% CI of (55.1–85), and the differences in sensitivity when comparing LAM-test results obtained from untreated vs. α-mannosidase treated urine had been deleted.
The sentence “the two participating UAIs using the Fischer exact test” in the statistical analysis sub-heading should have been “the LAM tests using the McNemar exact test”.
In the results section, the LAM-test sensitivity of 56.1% with 95% CI of (43.3–68.3) should have been 62.7 with 95% CI of (49.1–75), and the LAM-test sensitivity in PLWH with < 200 CD4 T cells/µl of 62.2% (95% CI 46.5–76.2) should have been of 71.8% with 95% CI of (55.1–85), the acronym “UIA” should have been “UAI”; the sentence “the defined gold standard composite” should have been “the defined reference standard”; the word “gold” has been eliminated; the sentence “composite gold referenced standard” should have been “composite reference standard”; the acronym “IAUs” should have been “UAI”, and the term “composite gold standard” should have been “composite reference standard”.
As a result, the authors have corrected Table 2. All sensitivity and specificity values have been corrected; the McNemar exact test has replaced the Fischer exact test for p value calculations, and these p values have been corrected; the footnote has been modified to reflect these changes.
The authors apologize for any inconvenience.
Reference
García JI, Meléndez J, Álvarez R, Mejía-Chew C, Kelley HV, Sidiki S, Castillo A, Mazariegos C, López-Téllez C, Forno D, Ayala N, Balada-Llasat J-M, Mejía-Villatoro CR, Wang S-H, Torrelles JB, Ikeda J. Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala. AIDS Res Therapy. 2020;17:62. https://doi.org/10.1186/s12981-020-00318-8.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
García, J.I., Meléndez, J., Álvarez, R. et al. Correction to: Accuracy of the tuberculosis point-of-care Alere determine lipoarabinomannan antigen diagnostic test using α-mannosidase treated and untreated urine in a cohort of people living with HIV in Guatemala. AIDS Res Ther 19, 48 (2022). https://doi.org/10.1186/s12981-022-00466-z
Accepted:
Published:
DOI: https://doi.org/10.1186/s12981-022-00466-z